Evolving with purpose in the CDMO industry
Bora’s 36,000 square metre facility in Zhunan, Taiwan  Interview with: Bobby Sheng, Group CEO & Chairman of Bora Pharmaceuticals The contract development and manufacturing organisation (CDMO) industry is undergoing structural recalibration, shifting from pure manufacturing to becoming valuable strategic partners, which means that scaling without strategy and growth without responsibility are no longer viable. So, … Read more